menu
    • menu

    Company profile for Themis Bioscience

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Themis has developed a sophisticated vaccine platform and broad pipeline based on the advanced understanding of immune system mechanisms. Initially focused on preventing infectious diseases, the Company has demonstrated the potential of its versatile platform through the rapid progression into Phase 2 clinical development for a vaccine against Chikungunya, a debilitating disease with global outbreak potential. Funded to date b...
    Themis has developed a sophisticated vaccine platform and broad pipeline based on the advanced understanding of immune system mechanisms. Initially focused on preventing infectious diseases, the Company has demonstrated the potential of its versatile platform through the rapid progression into Phase 2 clinical development for a vaccine against Chikungunya, a debilitating disease with global outbreak potential. Funded to date by leading EU-based VCs, Themis has also gained prestigious non-dilutive funding for emerging infectious disease indications.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Themis BioscienceAustria Flag
    Country
    Country
    Austria
    Address
    Address
    Muthgasse 11/2, 1190 Vienna
    Telephone
    Telephone
    +43 / 1 / 236 7151
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.themisbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/themisbio/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Themis_Bio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Merck, via Themis buy, moves first COVID vax into human testing
    Merck, via Themis buy, moves first COVID vax into human testing

    30 Jul 2020

    // Ben Adams FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/merck-via-its-themis-buy-to-move-first-covid-19-vaccine-into-clinical-development-q3

    Ben Adams FIERCEBIOTECH
    30 Jul 2020
    Share Share
    Merck to buy Austrian vaccine maker as it jumps into COVID-19 race
    Merck to buy Austrian vaccine maker as it jumps into COVID-19 race

    28 May 2020

    // J. Steenhuysen REUTERS

    https://in.reuters.com/article/health-coronavirus-merck/merck-to-buy-austrian-vaccine-maker-as-it-jumps-into-covid-19-race-idINKBN2321HP

    J. Steenhuysen REUTERS
    28 May 2020
    Share Share
    Themis collaborates with ABL Europe to manufacture its SARS-CoV-2 Vaccine
    Themis collaborates with ABL Europe to manufacture its SARS-CoV-2 Vaccine

    11 May 2020

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/themis-collaborates-with-abl-europe-to-manufacture-its-sars-cov-2-vaccine-candidate-in-france-301056590.html

    PR NEWSWIRE
    11 May 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search